Corbus Pharmaceuticals Holdings, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBP3d

   Corbus Pharmaceuticals updates investor presentation.

   • Filed Form 8-K on 2026-10-15.
   • Updated management presentation for investors.
   • Exhibit 99.1 includes investor presentation.
2. ROUTINESCHEDULE 13GCorbus Pharmaceuticals Holdings, Inc.CRBPSep 30

   Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P.

   RA CAPITAL MANAGEMENT, L.P., filed by

3. ROUTINE4Corbus Pharmaceuticals Holdings, Inc.CRBPSep 15

   Yong Ben, insider filing for CRBP

   Yong Ben, reporting

4. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPSep 14

   Current report

5. ROUTINE4Corbus Pharmaceuticals Holdings, Inc.CRBPAug 17

   Leonardo Viana Nicacio, insider filing for CRBP

   Leonardo Viana Nicacio, reporting

6. ROUTINESCHEDULE 13G/ACorbus Pharmaceuticals Holdings, Inc.CRBPAug 14

   Ownership stake disclosure by CITADEL ADVISORS LLC (amended)

   CITADEL ADVISORS LLC, filed by

7. ROUTINE4Corbus Pharmaceuticals Holdings, Inc.CRBPAug 12

   Nishant C Saxena, insider filing for CRBP

   Nishant C Saxena, reporting

8. ROUTINE4Corbus Pharmaceuticals Holdings, Inc.CRBPAug 10

   2 insider filings

   Sean F. Moran, insider filing for CRBP

   Show all 2

   • 4Insider filing for CRBPAug 10
   • 4Insider filing for CRBPAug 10

   Sean F. Moran, reporting

9. ROUTINE424B5Corbus Pharmaceuticals Holdings, Inc.CRBPAug 7

   Securities offering

10. ROUTINE144Corbus Pharmaceuticals Holdings, Inc.CRBPAug 7

    2 Form 144 notices

    Stifel, Nicolaus & Company, Inc CIAS /FA, planned sale of CRBP shares

    Show all 2

    • 144Planned insider sale of CRBP sharesAug 7
    • 144Planned insider sale of CRBP sharesAug 7

    Stifel, Nicolaus & Company, Inc CIAS /FA, reporting

11. NOTABLE10-QCorbus Pharmaceuticals Holdings, Inc.CRBPAug 6

    Quarterly report

12. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPAug 6

    Current report

13. ROUTINE3Corbus Pharmaceuticals Holdings, Inc.CRBPAug 4

    Leonardo Viana Nicacio, new insider at CRBP

    Leonardo Viana Nicacio, reporting

14. ROUTINESCHEDULE 13GCorbus Pharmaceuticals Holdings, Inc.CRBPJul 27

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

15. ROUTINE144Corbus Pharmaceuticals Holdings, Inc.CRBPJul 27

    Dominic Smethurst, planned sale of CRBP shares

    Dominic Smethurst, reporting

16. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPJul 6

    Current report

17. ROUTINES-8Corbus Pharmaceuticals Holdings, Inc.CRBPJun 17

    Employee stock plan registration

18. ROUTINE4Corbus Pharmaceuticals Holdings, Inc.CRBPJun 11

    3 insider filings

    John Kenneth Jenkins, insider filing for CRBP

    Show all 3

    • 4Insider filing for CRBPJun 11
    • 4Insider filing for CRBPJun 11
    • 4Insider filing for CRBPJun 11

    John Kenneth Jenkins, reporting

19. ROUTINE4Corbus Pharmaceuticals Holdings, Inc.CRBPJun 3

    Nishant C Saxena, insider filing for CRBP

    Nishant C Saxena, reporting

20. ROUTINES-8Corbus Pharmaceuticals Holdings, Inc.CRBPMay 29

    Employee stock plan registration

21. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPMay 26

    Current report

22. ROUTINE4Corbus Pharmaceuticals Holdings, Inc.CRBPMay 22

    2 insider filings

    Nishant C Saxena, insider filing for CRBP

    Show all 2

    • 4Insider filing for CRBPMay 22
    • 3New insider at CRBPMay 22

    Nishant C Saxena, reporting

23. ROUTINE4Corbus Pharmaceuticals Holdings, Inc.CRBPMay 21

    7 insider filings

    Winston Kung, insider filing for CRBP

    Show all 7

    • 4Insider filing for CRBPMay 21
    • 4Insider filing for CRBPMay 21
    • 4Insider filing for CRBPMay 21
    • 4Insider filing for CRBPMay 21
    • 4Insider filing for CRBPMay 21
    • 4Insider filing for CRBPMay 21
    • 3New insider at CRBPMay 21

    Winston Kung, reporting

24. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPMay 21

    Current report

25. ROUTINESCHEDULE 13G/ACorbus Pharmaceuticals Holdings, Inc.CRBPMay 14

    Ownership stake disclosure by Octagon Capital Advisors LP (amended)

    Octagon Capital Advisors LP, filed by

26. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPMay 14

    Current report

27. NOTABLE10-QCorbus Pharmaceuticals Holdings, Inc.CRBPMay 12

    Quarterly report

28. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPMay 12

    Current report

29. ROUTINEDEFA14ACorbus Pharmaceuticals Holdings, Inc.CRBPApr 16

    Additional proxy materials

30. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPApr 16

    Current report

31. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPApr 14

    Current report

32. ROUTINE8-KCorbus Pharmaceuticals Holdings, Inc.CRBPApr 7

    Current report

33. ROUTINEARSCorbus Pharmaceuticals Holdings, Inc.CRBPApr 2

    Annual report to shareholders

34. ROUTINEDEFA14ACorbus Pharmaceuticals Holdings, Inc.CRBPApr 2

    Additional proxy materials

35. ROUTINEDEF 14ACorbus Pharmaceuticals Holdings, Inc.CRBPApr 2

    Proxy statement

36. ROUTINE424B3Corbus Pharmaceuticals Holdings, Inc.CRBPMar 25

    Securities offering

37. ROUTINEEFFECTCorbus Pharmaceuticals Holdings, Inc.CRBPMar 23

    Registration declared effective

38. ROUTINES-3Corbus Pharmaceuticals Holdings, Inc.CRBPMar 11

    Securities offering

39. NOTABLE10-KCorbus Pharmaceuticals Holdings, Inc.CRBPMar 9

    Annual report

Older filings on EDGAR